NCPC(600812) 证券时报网·2025-01-17 03:41Group 1 - The stock price of North China Pharmaceutical has shown significant movement, increasing by 5.01% as of 11:13 AM today, with a trading volume of 31.48 million shares and a transaction amount of 167 million yuan, resulting in a turnover rate of 1.83% [1] - The company has released its latest earnings forecast, expecting a net profit of 125 million yuan for 2024, which represents a year-on-year growth of 2456.08% [1] - In the context of today's performance, other companies that announced their 2024 earnings forecasts include Huayuan Holdings, Zhongchong Co., and Jianlang Hardware, with stock price increases of 9.95%, 9.22%, and 6.69% respectively [1] Group 2 - The capital flow analysis indicates that North China Pharmaceutical has experienced a net inflow of main funds over the past five days, totaling 19.77 million yuan, with a net inflow of 7.71 million yuan on the previous trading day [1] - The latest margin trading data shows that as of January 16, the total margin balance for the stock is 159 million yuan, with a financing balance of 158 million yuan, and an increase of 547,500 yuan in the financing balance over the past five days, reflecting a growth rate of 0.35% [1]